556 results on '"Dieckmann, Klaus-Peter"'
Search Results
2. Testicular neoplasms: the interrelationships of serum levels of microRNA-371a-3p (M371) and classical tumor markers with histology, clinical staging, and age—a statistical analysis
3. Subsets of preoperative sex hormones in testicular germ cell cancer: a retrospective multicenter study
4. Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ
5. Nachsorge von Hodentumoren in der urologischen Praxis – historische Entwicklung und aktuelle Aspekte
6. Testicular germ cell tumours’ clinical stage I: comparison of surveillance with adjuvant treatment strategies regarding recurrence rates and overall survival—a systematic review
7. Paraneoplastic Hyperthyroidism in advanced testicular non-seminomatous germ cell tumors: Prevalence and clinical Management
8. Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours
9. Patterns of Disease Progression and Outcome of Patients With Testicular Seminoma Who Relapse After Adjuvant or Curative Radiation Therapy
10. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging
11. Associations of serum levels of microRNA-371a-3p (M371) with risk factors for progression in nonseminomatous testicular germ cell tumours clinical stage 1
12. A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis
13. Supplementary Table S4 from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
14. Supplementary Figure S1 from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
15. Data from Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study
16. The prognostic significance of lactate dehydrogenase levels in seminoma patients with advanced disease: an analysis by the Global Germ Cell Tumor Collaborative Group (G3)
17. Serum levels of microRNA-371a-3p are not elevated in testicular tumours of non-germ cell origin
18. Detection of recurrence through microRNA-371a-3p serum levels in a follow-up of stage I testicular germ cell tumors in the DRKS-00019223 study
19. 23/m mit schmerzhafter Vergrößerung des rechten Hodens: Vorbereitung auf die Facharztprüfung: Fall 3
20. Leydig-cell tumour of the testis: retrospective analysis of clinical and therapeutic features in 204 cases
21. Are serum levels of 25-hydroxy vitamin D reduced following orchiectomy in testicular cancer patients?
22. Correction to: Are serum levels of 25-hydroxy vitamin D reduced following orchiectomy in testicular cancer patients?
23. Application of miRNAs in the diagnosis and monitoring of testicular germ cell tumours
24. MicroRNA-371a-3p—The Novel Serum Biomarker in Testicular Germ Cell Tumors
25. Adjuvant carboplatin therapy in patients with clinical stage 1 testicular seminoma: is long-term morbidity increased?
26. Die Urologie – ein persönlicher Rückblick und ein vorsichtiger Blick in die Zukunft
27. No evidence for seasonal variations of the incidence of testicular germ cell tumours in Germany
28. Familial Testicular Germ Cell Tumor in Two Brothers With Emery Dreifuss Muscular Dystrophy Caused by an FHL-1 Mutation: A Case Report
29. Tertiary Syphilitic Gumma Mimicking Testicular Neoplasms
30. Major complications of post-chemotherapy retroperitoneal lymph node dissection in a contemporary cohort of patients with testicular cancer and a review of the literature
31. Keimzellneoplasie in situ (GCNIS): Therapie
32. Maligne Hodentumoren: Onkologische Kennzeichen und Diagnostik
33. Maligne Hodentumoren: Epidemiologie und Ätiologie
34. Maligne Hodentumoren: Therapie des Primärtumors
35. Nichtgerminale Hodentumoren
36. Is There Still an Indication for Radiotherapy in Seminoma Clinical Stages I–IIA/B?
37. Real-Time Elastography and Contrast-Enhanced Ultrasonography in the Evaluation of Testicular Masses: A Comparative Prospective Study
38. Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ
39. Testicular Neoplasms: Primary Tumour Size Is Closely Interrelated with Histology, Clinical Staging, and Tumour Marker Expression Rates—A Comprehensive Statistical Analysis
40. Contralateral biopsies in patients with testicular germ cell tumours: What is the rationale?
41. Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer
42. Maligne Hodentumoren
43. Testicular seminoma clinical stage 1: treatment outcome on a routine care level
44. Serum Levels of MicroRNA-371a-3p (M371) Can Predict Absence or Presence of Vital Disease in Residual Masses After Chemotherapy of Metastatic Seminoma
45. M371-Test bei Keimzelltumoren
46. Nachsorge von Hodentumoren in der urologischen Praxis – historische Entwicklung und aktuelle Aspekte
47. Saisonale Häufung der Inzidenz von testikulären Keimzelltumoren
48. Single-course bleomycin, etoposide, and cisplatin (1xBEP) as adjuvant treatment in testicular nonseminoma clinical stage 1: outcome, safety, and risk factors for relapse in a population-based study
49. Myokardinfarkt bei jungem Seminompatient während Chemotherapie mit Cisplatin, Etoposid und Bleomycin (PEB-Schema)
50. Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.